Analyst Rating Update on Varian Medical Systems (VAR)

Varian Medical Systems (VAR) : Zacks Investment Research ranks Varian Medical Systems (VAR) as 2, which is a Buy recommendation. 3 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. 1 more believe that the stock has more downside risks, hence they propose a Strong Sell. A total of 1 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 5 research analysts is 2.06, which indicates as a Buy.

Varian Medical Systems (VAR) : Currently there are 5 street experts covering Varian Medical Systems (VAR) stock. The most bullish and bearish price target for the stock is $102 and $86 respectively for the short term. The average price target of all the analysts comes to $92.8. The estimated standard deviation from the target is $6.98.

Company shares have received an average consensus rating of Hold for the current week


Varian Medical Systems (NYSE:VAR): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $94.46 and $94.10 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $94.86. The buying momentum continued till the end and the stock did not give up its gains. It closed at $94.65, notching a gain of 0.20% for the day. The total traded volume was 882,874 . The stock had closed at $94.46 on the previous day.

Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical, scientific, and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer, taking X-ray images and protecting ports and borders. The Companys products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, accessories, information management, treatment planning and image processing software. The Companys customers include university research and community hospitals, private and governmental institutions, healthcare agencies, doctors offices and cancer care clinics.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.